Member Info for euclid55

Hello Trueway,

if you do work with Carl, as you know you have to very careful what you say on public forums.

I do hope that they start the clinical testing soon

Thanks

Hi Bushmaster, just found his info on the Nottingham Trent University:

https://www.ntu.ac.uk/staff-profiles/education/bob-stevens

Professor of SMART Materials and Devices (Part time)

Research Areas

Electro spinning of natural and synthetic polymers to produce microstructured functional nanofibrous membranes for applications in Life Science, Healthcare, Energy and Environment
Point of Care and Self Diagnostic devices for early detection of disease (Type II Diabetes, Cadiovascular)
Manufacturing techniques and processes to produce high quality human tissue suitable for cell based medical implants to treat disease and injury. (Therapies for Age related Macular Degeneration, Spinal Cord Repair)
Manufacturing of chronic in vitro 3D tissue models to help discover new drugs to treat Parkinson's Disease and other neurodegenerative disorders.
Nano-electrospray of nanomaterials and biomolecules for advanced functional coatings, patterned and precision surfaces
Offset and Lithographic Printing for low cost production of flexible hybrid electronics and optoelectronics
Interfacing printed flexible and stretchable electrodes with manufactured human tissue
Commercial activity

Director of Flexotronix Limited - Manufacture of Flexible Hybrid Electronics

Hi Bushmaster, where did you find Professor S Roberts CV please

Trueway, what do you mean by get the go ahead please?

"I have followed there trials personally and anytime now they will get the go ahead"

Many go on about us being worth simialr to NCYT, but don't go forgetting their profits over 6 months

Operating profit of €48.3m compared to a loss of €0.7m in H1 2019, driven by the growth in sales in molecular products business

• Profit after tax of €40.2m compared to a loss of €1.2m in H1 2019

https://www.investegate.co.uk/novacyt-s-a---ncyt-/rns/half-year-2020-results/202009170700042380Z/

Don't forget NCYT profit for 6 months:

Operating profit of €48.3m compared to a loss of €0.7m in H1 2019, driven by the growth in sales in molecular products business

• Profit after tax of €40.2m compared to a loss of €1.2m in H1 2019

https://www.investegate.co.uk/novacyt-s-a---ncyt-/rns/half-year-2020-results/202009170700042380Z/

how did you calculate their £600k cash balance?

They still need to complete the clinical tests to see the final results - no matter how long they have been in this business - it's all down to clinical testing results - so it's not a given on a 100% basis

Hi Woodstock, are you invested in BRH, what do you make of their 5 min Covid testing device from the Sheffield Univ?

Thanks Mr Euclid

Vivian Hallam and Jonathan Freeman have undertaken to the Board not to sell these shares for a period of at least one year from the time of issue except in certain circumstances such as in a takeover or death.

Tom visual, your forgetting about Avct's antigen test?

Carl's test potentially is the only antigen test that may meet MHRA Guidelines Desired Criterion

Did I hear correct in yesterday's interview that they are now producing / going to produce 5m masks per month?

Assuming RMS make approx 7.5p per mask profit

5m masks per month X 7.5p = £375,000 per month X 12 = £4.5m ptp

£4.5m div 1.378B shs = 0.00327p Eps - If RMS trade at 15 Times EPS = 0.049p X 1.378B shs = £67.5m market cap

20 X EPS = 6.5p x 1.378B shs = £90m

Deal with Rolls Royce in March 2018

Rolls-Royce has signed a collaboration agreement with technology start-up Superdielectrics to explore the potential of using polymers with recently discovered remarkable properties to create next generation high energy storage technology

Https://www.britishplastics.co.uk/materials/superdielectrics-breakthrough-aids-rolls-royce-to-make-most-/

Tesla CEO Elon Musk has already backed supercapacitors but said “we need a breakthrough in energy density” on his social media accounts. The research group suggests that this may be the breakthrough Musk was referring to. China already has a fleet of supercapacitor-equipped buses, although these do not yet have the considerable range the research group claims is possible with the further development.

Heathcote explained that the group has been working in secret on the project until this point, having filed worldwide patents only last week.

https://www.autocar.co.uk/car-news/new-cars/evs-could-be-fully-charged-seconds-following-supercapacitor-revolution

Dr Brendan Howlin of the University of Surrey said: “There is a global search for new energy storage technology and this new ultra-capacity supercapacitor has the potential to open the door to unimaginably exciting developments.”

Heathcote also said: “We are now actively seeking commercial partners in order to supply our polymers and offer assistance to build these ultra-high-energy density storage devices.” The company also cites Musk's vested interest in the technology, suggesting they will be expecting to make contact with Tesla about the proposition.

According to their website they only developed superC's in 2018.

Looking to float

Sunday Times mention Michael Spencer of Icap invests £8m into them.

Says they have a deal with Rolls Royce

Puts a value of £250m!
So either Cpx is managed incorrectly & fails to tie up good comm value deals. Or they are targetting their SuperC's in low volume markets.

What makes this co"s supercapacitors different to Cpx's?

https://www.superdielectrics.com/our-technology.html

If this was a buy, it didn't really move the price at all - any thoughts

was the 200,000 a sell or a buy - looks priced as a sell - so a net 100,000 buy

Actipix D100 Real time UV Imaging system